Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
Mem. Inst. Oswaldo Cruz
;
109(4): 499-501, 03/07/2014. tab, graf
Article
in English
| LILACS
| ID: lil-716309
ABSTRACT
Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Herpes Zoster
/
Antimony
/
Antiprotozoal Agents
Type of study:
Observational study
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
English
Journal:
Mem. Inst. Oswaldo Cruz
Journal subject:
Tropical Medicine
/
Parasitology
Year:
2014
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Mato Grosso/BR
Similar
MEDLINE
...
LILACS
LIS